Answers are grounded in this paper and cite their sources.
Maytansine given in a 3-day course q3 weeks produced only five responses (3%) in 163 evaluable adults with advanced cancer. The dose schedule employed is not recommended for further study.
No takes yet. Share an insight, caveat, or question.
Ravry et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: